首页> 美国卫生研究院文献>Journal of Experimental Clinical Cancer Research : CR >Shenqi fuzheng an injection concocted from chinese medicinal herbs combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review
【2h】

Shenqi fuzheng an injection concocted from chinese medicinal herbs combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review

机译:参芪扶正注射液由中草药炮制而成结合铂类化学疗法治疗晚期非小细胞肺癌:系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPlatinum-based chemotherapy has been a standard therapy for advanced non-small cell lung cancer (NSCLC), but it has high toxicity. In China, Shenqi Fuzheng, a newly developed injection concocted from Chinese medicinal herbs has been reported that may increase efficacy and reduce toxicity when combined with platinum-based chemotherapy, but little is known about it outside of China. The aim of this study was to systematically review the existing clinical evidence on Shenqi Fuzheng Injection(SFI) combined with platinum-based chemotherapy for advanced NSCLC.
机译:背景基于铂的化学疗法已成为晚期非小细胞肺癌(NSCLC)的标准疗法,但毒性很高。在中国,据报道,由中草药炮制的新开发的沉奇扶正注射液与铂类化学疗法联合使用可提高疗效并降低毒性,但在中国以外鲜为人知。这项研究的目的是系统地审查参芪扶正注射液(SFI)联合铂类化疗治疗晚期NSCLC的现有临床证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号